期刊文献+

晚期糖基化终末产物对心血管损伤的机制及防治策略 被引量:5

Underlying mechanisms and preventive strategies of advanced glycation end products in cardiovascular injury
下载PDF
导出
摘要 晚期糖基化终末产物(advanced glycosylation end products,AGEs)是糖酮或醛基与蛋白、脂质、氨基酸的自由氨基经不可逆反应所形成的物质,是非酶糖基化反应的最终产物。研究发现在动脉硬化、心肌舒张异常及内皮功能紊乱等心血管疾病中都出现AGEs水平的增加,并且抑制AGEs的产生或作用具有心血管保护作用。因此,AGEs可以作为防治心血管疾病的一个潜在靶点。本文重点综述了AGEs的来源、心血管损伤机制及防治策略。 Advanced glycation end products (AGEs) are a complex group of compounds that are formed when reducing sugar or aldehyde reacts irreversibly in a non-enzymatic manner with free amino in proteins, lipoids or amino acids. Increased level of AGEs has been found in cardiovascular diseases such as arterial stiffening, myocardial relaxation abnormalities and endothelial dysfunction. Furthermore, accumulation of AGEs contributes to changes in the structure and function of cardiovascular system. Thus, it is possible to prevent or cure cardiovascular diseases by inhibition of AGEs. This review mainly summarizes the sources of AGEs, the underlying mechanisms in induction of cardiovascular injury and the preventive strategies.
作者 张仁宇 任超 秦兴华 李婷婷 杨红艳 贾敏 张星 ZHANG Ren-yu REN Chao QIN Xing-hua LI Ting-ting YANG Hong-yan JIA Min ZHANG Xing(Department of Aerospace Medicine University, Xi'an 710032, Shaanxi, China)
出处 《心脏杂志》 CAS 2017年第2期241-245,共5页 Chinese Heart Journal
基金 国家自然科学基金项目资助(31500932 31500928)
关键词 晚期糖基化终末产物 心血管损伤 羧甲基赖氨酸 advanced glycation end products cardiovascular injury carboxymethyl-lysine
  • 相关文献

参考文献3

二级参考文献165

  • 1李丹,吕安林,贾国良.糖尿病对冠状动脉介入术后心功能的影响[J].心脏杂志,2005,17(4):362-364. 被引量:2
  • 2黄晨,高建苑,吴利平,王晓明,苏慧,郑敏文.EBT检测对冠脉病变危险因素的价值[J].心脏杂志,2005,17(4):380-382. 被引量:2
  • 3王凌燕,蔡高军.餐后高血糖对心血管系统的影响[J].心脏杂志,2006,18(3):359-361. 被引量:5
  • 4Li Lin.RAGE on the Toll Road?[J].Cellular & Molecular Immunology,2006,3(5):351-358. 被引量:12
  • 5Kikuchi Y,Kobayashi S,Hemmi N,et al.Galectin-3-positive cell infiltration in human diabetic nephropathy.Nephrol Dial Transplant,2004,19(3):602-07.
  • 6Wendt TM,Tanji N,Guo J,et al.RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.Am J Pathlo,2003,162(4):1123-37.
  • 7Ha TS,Song C J,Lee JH.Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium.Pediatr Nephrol,2004,19(11):1219-24.
  • 8Greven WL,Waanders F,Nagai R,et al.Mesangial accumulation of GA-pyridine,a noval glycolaldehyde-derived AGE,in human renal disease.Kidney Int,2005,68(2):595-602.
  • 9Yamagishi S,Inagaki Y,Okamoto T,et al.Advanced glycation end product induced apoptosis and overpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 ind human-cultured mesaugial cells.J Biol Chem,2002,277 (23):20309-15.
  • 10Zhou G,Li C,Cai L.Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.Am J Pathol,2004,165(5):2033-43.

共引文献82

同被引文献70

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部